MPWT
AMLX icon

MassMutual Private Wealth & Trust’s Amylyx Pharmaceuticals AMLX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.54K Buy
420
+138
+49% +$2.13K ﹤0.01% 1522
2026
Q1 		$3.92K Buy
282
+129
+84% +$1.81K ﹤0.01% 1762
2025
Q4 		$1.85K Sell
153
-87
-36% -$1.18K ﹤0.01% 2015
2025
Q3 		$3.26K Buy
+240
New +$2.26K ﹤0.01% 1841

Other funds holding AMLX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
FRM
Fox Run Management Greenwich, Connecticut $603M AUM 32% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

MassMutual Private Wealth & Trust's AMLX Position: Q2 2026 in Review

MassMutual Private Wealth & Trust increased its Amylyx Pharmaceuticals (AMLX) stake by 49% in Q2 2026, buying an estimated $2.13K and bringing the position to 420 shares worth $7.54K. The position accounts for ﹤0.01% of the portfolio, ranked #1522.

MassMutual Private Wealth & Trust first reported a position in AMLX in Q3 2025 and has held it in 4 quarters since. 34 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • MassMutual Private Wealth & Trust held 420 shares of Amylyx Pharmaceuticals worth $7.54K as of Q2 2026.
  • MassMutual Private Wealth & Trust bought 138 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $2.13K.
  • Amylyx Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1522 holding.
  • MassMutual Private Wealth & Trust first reported a position in Amylyx Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 34 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.